FUMAGALLI, GIORGIO GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 1.313
EU - Europa 628
AS - Asia 227
AF - Africa 5
Totale 2.173
Nazione #
US - Stati Uniti d'America 1.310
RU - Federazione Russa 375
IE - Irlanda 77
CN - Cina 70
IT - Italia 69
HK - Hong Kong 68
SG - Singapore 51
SE - Svezia 40
PL - Polonia 22
IN - India 18
FR - Francia 13
GB - Regno Unito 11
JO - Giordania 10
DE - Germania 9
FI - Finlandia 8
KR - Corea 6
VN - Vietnam 4
CA - Canada 3
CI - Costa d'Avorio 3
MU - Mauritius 2
UA - Ucraina 2
GR - Grecia 1
LT - Lituania 1
Totale 2.173
Città #
Santa Clara 347
Fairfield 150
Ashburn 88
Woodbridge 86
Dublin 77
Seattle 61
Cambridge 59
Houston 54
Hong Kong 50
Dearborn 49
Wilmington 44
Singapore 42
Chandler 41
Altamura 33
Lawrence 30
Warsaw 22
Princeton 21
Ann Arbor 20
New York 18
Shanghai 15
Boston 14
Beijing 13
Kent 13
Moscow 13
Mumbai 13
Buffalo 12
Florence 11
San Diego 9
Medford 8
Milan 7
Lambeth 6
Seoul 6
Boardman 5
Bremen 5
Falls Church 5
Los Angeles 5
Dong Ket 4
Helsinki 4
Norwalk 4
Pune 4
Abidjan 3
Hefei 3
Nanjing 3
Redmond 3
Toronto 3
Fiesole 2
Hillsboro 2
Livorno 2
Pedrengo 2
West Jordan 2
Andover 1
Chicago 1
Ferrara 1
Guangzhou 1
Heidelberg 1
Jinan 1
Kunming 1
Lappeenranta 1
Laurel 1
London 1
Lucca 1
Luoyang 1
Munich 1
Nanchang 1
New Bedfont 1
Philadelphia 1
Rome 1
Romola 1
Rui'an 1
Trumbull 1
Washington 1
Wuhan 1
Wuxi 1
Yubileyny 1
Zhengzhou 1
Totale 1.518
Nome #
Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study 138
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 136
Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort 132
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 128
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study 126
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 126
Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI) 121
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 119
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 119
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 112
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 109
Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study 99
Disease-related cortical thinning in presymptomatic granulin mutation carriers 79
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 75
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 69
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 69
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 68
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 63
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 57
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 56
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 49
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study 44
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 34
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort 33
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 31
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study 19
Totale 2.211
Categoria #
all - tutte 7.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.425


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 0 0 0 0 66 70 45 46 20 14 10
2020/2021177 13 11 10 12 15 3 3 9 30 42 18 11
2021/2022118 1 1 10 3 1 8 1 15 8 9 16 45
2022/2023296 33 78 20 15 7 46 52 13 25 0 6 1
2023/2024262 14 18 28 17 14 34 11 64 5 13 34 10
2024/2025898 53 144 85 205 376 35 0 0 0 0 0 0
Totale 2.211